🇺🇸 FDA
Pipeline program

Placebo for PRAX-628, PRAX-628

PRAX-628-321

Phase 3 small_molecule active

Quick answer

Placebo for PRAX-628, PRAX-628 for Focal Epilepsy is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Focal Epilepsy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials